Literature DB >> 19649143

Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin.

Saveria Pastore1, Francesca Mascia.   

Abstract

Entities:  

Year:  2008        PMID： 19649143      PMCID： PMC2600505          DOI： 10.1586/17469872.3.5.525

Source DB:  PubMed          Journal:  Expert Rev Dermatol        ISSN： 1746-9872


× No keyword cloud information.
  13 in total

1.  Exacerbation of psoriasis after treatment with an EGFR tyrosine kinase inhibitor.

Authors:  Markella-Pagona Zorzou; Alexandros Stratigos; Eleni Efstathiou; Aristotle Bamias
Journal:  Acta Derm Venereol       Date:  2004       Impact factor: 4.437

2.  Photosensitive rash due to the epidermal growth factor receptor inhibitor erlotinib.

Authors:  Minnelly Luu; Susan E Lai; Jyoti Patel; Joan Guitart; Mario E Lacouture
Journal:  Photodermatol Photoimmunol Photomed       Date:  2007-02       Impact factor: 3.135

Review 3.  EGFR antagonists in cancer treatment.

Authors:  Fortunato Ciardiello; Giampaolo Tortora
Journal:  N Engl J Med       Date:  2008-03-13       Impact factor: 91.245

4.  ERK1/2 regulates epidermal chemokine expression and skin inflammation.

Authors:  Saveria Pastore; Francesca Mascia; Feliciana Mariotti; Cristina Dattilo; Valentina Mariani; Giampiero Girolomoni
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

5.  The Koebner-phenomenon in epidermal growth factor receptor inhibitor-induced cutaneous adverse effects.

Authors:  Peter Arne Gerber; Elaine Enderlein; Bernhard Homey
Journal:  J Clin Oncol       Date:  2008-06-01       Impact factor: 44.544

Review 6.  Mechanisms of cutaneous toxicities to EGFR inhibitors.

Authors:  Mario E Lacouture
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

7.  Inhibition of the epidermal growth factor receptor increases expression of genes that stimulate inflammation, apoptosis, and cell attachment.

Authors:  Craig D Woodworth; Evan Michael; Dan Marker; Sarah Allen; Laura Smith; Matthias Nees
Journal:  Mol Cancer Ther       Date:  2005-04       Impact factor: 6.261

8.  Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation.

Authors:  Francesca Mascia; Valentina Mariani; Giampiero Girolomoni; Saveria Pastore
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

Review 9.  Beyond wavy hairs: the epidermal growth factor receptor and its ligands in skin biology and pathology.

Authors:  Marlon R Schneider; Sabine Werner; Ralf Paus; Eckhard Wolf
Journal:  Am J Pathol       Date:  2008-06-13       Impact factor: 4.307

Review 10.  The Koebner phenomenon: review of the literature.

Authors:  G Weiss; A Shemer; H Trau
Journal:  J Eur Acad Dermatol Venereol       Date:  2002-05       Impact factor: 6.166
View more
  11 in total

1.  EGFR signaling blunts allergen-induced IL-6 production and Th17 responses in the skin and attenuates development and relapse of atopic dermatitis.

Authors:  Zhonghua Zhang; Chang Xiao; Aaron M Gibson; Stacey A Bass; Gurjit K Khurana Hershey
Journal:  J Immunol       Date:  2013-12-13       Impact factor: 5.422

2.  Genetic Basis of Irritant Susceptibility in Health Care Workers.

Authors:  Berran Yucesoy; Yerkebulan Talzhanov; M Michael Barmada; Victor J Johnson; Michael L Kashon; Elma Baron; Nevin W Wilson; Bonnie Frye; Wei Wang; Kara Fluharty; Rola Gharib; Jean Meade; Dori Germolec; Michael I Luster; Susan Nedorost
Journal:  J Occup Environ Med       Date:  2016-08       Impact factor: 2.162

3.  Decreased levels of EGF in plasma of children with autism spectrum disorder.

Authors:  Charity Onore; Judy Van de Water; Paul Ashwood
Journal:  Autism Res Treat       Date:  2012-03-05

4.  ADAM17/EGFR axis promotes transglutaminase-dependent skin barrier formation through phospholipase C γ1 and protein kinase C pathways.

Authors:  Cristina Wolf; Yawen Qian; Matthew A Brooke; David P Kelsell; Claus-Werner Franzke
Journal:  Sci Rep       Date:  2016-12-22       Impact factor: 4.379

5.  Decreased Epidermal Growth Factor (EGF) Associated with HMGB1 and Increased Hyperactivity in Children with Autism.

Authors:  Anthony J Russo
Journal:  Biomark Insights       Date:  2013-04-04

6.  Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation.

Authors:  Claus-Werner Franzke; Cristina Cobzaru; Antigoni Triantafyllopoulou; Stefanie Löffek; Keisuke Horiuchi; David W Threadgill; Thomas Kurz; Nico van Rooijen; Leena Bruckner-Tuderman; Carl P Blobel
Journal:  J Exp Med       Date:  2012-05-07       Impact factor: 14.307

7.  Increased Epidermal Growth Factor Receptor (EGFR) Associated with Hepatocyte Growth Factor (HGF) and Symptom Severity in Children with Autism Spectrum Disorders (ASDs).

Authors:  Anthony J Russo
Journal:  J Cent Nerv Syst Dis       Date:  2014-09-09

8.  Decreased Phosphorylated Protein Kinase B (Akt) in Individuals with Autism Associated with High Epidermal Growth Factor Receptor (EGFR) and Low Gamma-Aminobutyric Acid (GABA).

Authors:  Anthony J Russo
Journal:  Biomark Insights       Date:  2015-10-14

9.  Epidermal Growth Factor Attenuated the Expression of Inflammatory Cytokines in Human Epidermal Keratinocyte Exposed to Propionibacterium acnes.

Authors:  Ji Min Kim; Jung Eun Choo; Heun Joo Lee; Ki Nam Kim; Sung Eun Chang
Journal:  Ann Dermatol       Date:  2017-12-26       Impact factor: 1.444

10.  Epidermal Growth Factor Relieves Inflammatory Signals in Staphylococcus aureus-Treated Human Epidermal Keratinocytes and Atopic Dermatitis-Like Skin Lesions in Nc/Nga Mice.

Authors:  Sun Young Choi; You Jin Lee; Ji Min Kim; Hyun Ji Kang; Sang Hyun Cho; Sung Eun Chang
Journal:  Biomed Res Int       Date:  2018-05-15       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.